Review on hepatitis C virus: Variability and consequences;Mise au point sur le virus de l'hepatite C: Variabilite et implications

Transfusion Clinique et Biologique

Volumn 5, Issue 2, 1998, Pages 147-165

  Lunel, F ^a   Stuyver, L ^b   Brechot, C ^c   Maertens, G ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INNOGENETICS   (Belgium)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Genome; Hepatitis C virus; Physiopathology; RNA; Variability

Indexed keywords

VIRUS RNA;

BLOOD TRANSFUSION; CANCER RISK; DISEASE CARRIER; GENOME; GEOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HEREDITY; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER DISEASE; PATHOPHYSIOLOGY; REVIEW;

EID: 0032452620     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(98)80005-0     Document Type: Article

References (88)

1. 1 Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989 ; 244 : 359-62
2. 2 Saito I, Miyamura T, Ohbayashi A, Harada H, Katyama T, Kikuchi S et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990 ; 87 : 6547-9
3. 3 Kuo G, Choo QL, Alter HJ et al. An assay for circulating anti-bodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989 ; 244 : 362-4
4. 4 Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991 ; 14 : 381-8
5. 5 Simmonds P, Alberti A, Alter H, Bonino F, Bradley DW, Brechot C et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994 ; 19 : 1321-4
6. 6 Stuyver L, Wyseur A, Van Arnhem W, Lunel F, Laurent-Puig P, Pawlotsky JM et al. Hepatitis C virus genotyping by means of 5′UR/core line probe assays and molecular analysis of untypable samples. Virus Res 1995 ; 38 : 137-57
7. 7 Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995 ; 108 : 1088-96
8. 8 Bradley DW. The agents of non A non B viral hepatitis. J Virol Methods 1985 ; 10 : 307-19
9. 9 Khan NC, Hollinger FB. Non A non B hepatitis agent. Lancet 1986 ; i : 41
10. 10 Bradley DW, Mc Caustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE. Post-transfusion non A non B hepatitis in chimpanzees: physical evidence that the tubule-forming agent is a small, envelopped virus. Gastroenterology 1985 ; 88 : 773-9
11. 11 Ile LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH. Determination of the size of non A non B hepatitis virus by filtration. J Infect Dis 1987 ; 155 : 636-40
12. 12 Hoofnagle JH, Gerety RJ, Tabor E, Feinstone SM, Barker LF, Purcell RH. Transmission of non A non B hepatitis. Ann Int Med 1977 ; 87 : 14-20
13. 13 Bréchot C. Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci (Suppl) 1996 ; 41 : 6-21
14. 14 Maertens G, Stuyver L. Genotypes and genetic variations of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, eds. The Molecular Medicine of Viral Hepatitis. John Willey & Sons Ltd; 1997
15. 15 Matsuura Y, Miyamura T. The molecular biology of hepatitis C virus. Semin Virol 1993 ; 4 : 297-304
16. 16 Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994 ; 68 : 3631-41
17. 17 Lin C, Pragai BM, Grakoui A, Xu J, Rice CM. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 1994 ; 68 : 8147-57
18. 18 Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990 ; 87 : 2057-61
19. 19 Heinz FX. Comparative molecular biology of flaviviruses and hepatitis C virus. Arch Virol (Suppl) 1992 ; 4 : 163-71
20. 20 Major M, Feinstone S. The molecular biology of hepatitis C virus. Hepatology 1997 ; 25 : 1527-38
21. 21 Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994 ; 75 : 1755-60
22. 22 Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus: detection of intracellular virus particles by electron microscopy [comments]. Hepatology 1996 ; 23 : 205-9
23. 23 Choo S, So H, Cho JM, Ryu W. Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. J Gen Virol 1995 ; 76 : 2337-41
24. 24 Shin CM, Chen CM, Chen SY, Lee YHW. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995 ; 69 : 1160-71
25. 25 Kirn DW, Suzuki R, Harada T, Saito I, Miyamura T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 1994 ; 47 : 211-20
26. 26 Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995 ; 208 : 653-61
27. 27 Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M et al. A quantitative test to estimate neutralizing antibodies to hepatitis C virus cytofluorometric assessment of envelop glycoprotein E2 binding to target cell. Proc Natl Acad Sci USA 1996 ; 93 : 1759
28. 28 Reed KE, Grakoui A, Rice CM. Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol 1996 ; 69 : 4127-36
29. 29 Santolini E, Pacini L, Fipaldini C, Migliaccio G, Monica N. The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol 1995 ; 69 : 7461-71
30. 30 Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995 ; 69 : 1575-81
31. 31 Chambers TJ, Hahn CS, Galler R et al. Flavivirus genome organization, expression, and replication. Ann Rev Microbiol 1990 ; 44 : 649-88
32. 32 Lin C, Thomson JA, Rice CM. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 1995 ; 69 : 4376-80
33. 33 Enomoto N, Sakuma L, Asahina Y, Kurosaki M, Murakami T, Yamamoto C et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus Ib infection. N Engl J Med 1996 ; 334 : 77
34. 34 Enomoto N, Sakuma L, Asahina Y, Kurosaki M, Murakami T, Yamamolo C et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus Ib. J Clin Invest 1995 ; 96 : 224
35. 35 Zeuzem S, Lee JH, Roth W. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 1997 ; 25 : 740-4
36. 36 Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the reponse to recombinant interferon-alfa therapy in French patients. J Hepatol 1997 ; 27 : 72-7
37. 37 Fukushi S, Katayama K, Kurihara C, Ishiyama N, Hoshino FB, Ando T, Oya A. Complete 5′ noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem Biophys Res Commun 1994 ; 1992 : 425-32
38. 38 Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus. RNA 1996 ; 2 : 955-68
39. 39 Honda M, Ping LH, Rijnbrand RCA, Amphlett E, Clarke B, Rowlands D, Lemon SM. Structural requirements for initation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 1996 ; 222 : 3142
40. 40 Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry sit within hepatitis C virus RNA. J Virol 1992 ; 66 : 1476-83
41. 41 Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990 ; 87 : 9524
42. 42 Takamizawa A, Mori C, Fuke L, Manabe S, Murakami S, Fujita J et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991 ; 65 : 1105
43. 43 Chen P, Lin MH, Tai KF, Liu PC, Lin CJ, Chen DS. The Taiwanese hepatitis C virus genome: sequence determination and mapping of the 5′ terminal of viral genomic and antigenornic RNA. Virology 1992 ; 188 : 102-13
44. 43b Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp-Olson P et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly (A) tails at the 3′ end. Proc Natl Acad Sci USA 1991 ; 88 : 1711-15
45. 44 Tanaka T, Kato N, Cho MJ, Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem Biophys Res Commun 1995 ; 215 : 744-9
46. 45 Yamaha N, Tanikara K, Takada A, Yorihuzi T, Tsutsumi M, Shimomura H et al. Genetic organization and diversity of the 3′ noncoding region of the hepatitis C virus genome. Virology 1996 ; 223 : 255-61
47. 46 Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K. Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 1996 ; 70 : 3307-12
48. 47 Smith DB, Pathirina S, Davidson F, Lawlor Emer, Power J, Lee Yap P, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol 1997 ; 78 : 321-8
49. 48 Abrignani S. Immune response throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 1997 ; 19 (1): 47-56
50. 49 Farci P, Bukh J, Purcell RH. The quasi-species of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997 ; 19 (1): 5-26
51. 50 Koziel MJ, Walker BD. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection. Springer Semin Immunonopathol 1997 ; 19, 1 : 69-84
52. 51 Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of B-lipo-proteins and immunoglobulins. Med Microbiol Immunol 1993 ; 182 : 329-34
53. 52 Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S. Extraordinarily low density of hepatitis C virus estimated by a sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 1992 ; 73 : 715-8
54. 53 Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991 ; 88 : 3392
55. 54 Okamoto H, Kurai K, Okada SL, Yamamoto K, Lizuka H, Tanaka T et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992 ; 188 : 331
56. 55 Zeuzem S, Schmidt JM, Lee J-H, Ruster B, Roth WK. Dynamics of HCV turnover in vivo. Hepatology 1995 ; 22 : 287A
57. 56 Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of Hepatitis C virus quasi-species in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 1994 ; 75 : 1361-9
58. 57 Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995 ; 76 : 1197-204
59. 58 Kurosaki M, Enomoto N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993 ; 18 : 1293-9
60. 59 White MB, Carvalho M, Derse D, O'Brien SJ, Dean M. Detecting single base substitutions as heteroduplex Polymorphisms. Genomics 1992 ; 12 : 301-16
61. 60 Wilson JJ, Polyak SJ, Day TD, Gretch R. Characterization of simple and complex hepatitis C virus quasi-species by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol 1995 ; 76 : 1763-71
62. 61 Mellor J, Holmes EC, Jarvis L, Yap P, Simmonds P. The International HCV Collaborative study Group. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 1995 ; 76 : 2493-507
63. 62 Stuyver L, Van Arnhem V, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994 ; 91 : 10134-8
64. 63 Tokita H, Okamoto H, Lizuka H, Kishimoto J, Tsuda F, Lesmana LA et al. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol 1996 ; 77 : 293-301
65. 64 Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracting infectious sources. J Gen Virol 1992 ; 73 : 673-9
66. 65 Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993 ; 74 : 1093-102
67. 66 Mondelli MU, Cerino A, Bonino F, Cividini A, Maccabruni A, Anco M et al. Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J Clin Microbiol 1995 ; 32 : 2523-7
68. 67 Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of the type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993 ; 31 : 1493-503
69. 68 Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994 ; 19 : 1347-53
70. 69 Chang K-M, Rehermann B, Chisari FV. Immunopathology of hepatitis C. Springer Semin Immunopathol 1997 ; 19 (1): 57-68
71. 70 Benvegnü L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correletion between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997 ; 25 : 211-5
72. 71 Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case control study. Gastroenterology 1996 ; 111 : 199
73. 72 Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasi-species and genotypes. Semin Liver Dis 1995 ; 15 : 41-63
74. 73 Poynard T, Bedossa P, Opolon P for the Obsvirc, Metavir, Clinivir, and Dosvirc groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 ; 349 : 825-32
75. 74 Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994 ; 20 : 1144-51
76. 75 Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995 ; 69 : 3893-6
77. 76 Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996 ; 24 : 778-89
78. 77 Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C, and the collaborative study group. Hepatitis C virus types b (II) infection in France and Italy. Ann Intern Med 1995 ; 122 : 161-8
79. 78 Brouwer JT, Nevens F, Kleter GEM, Elewant A, Adler M, Brenard R et al. Efficacy of interferon dose and factors predictive of sustained response in chronic hepatitis C: final results of a Benelux multicentre study in 350 patients. J Hepatol 1995 ; 23 (suppl 1) : 85 (abstract)
80. 79 Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M et al. Pre-treatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995 ; 22 : 1050-6
81. 80 Chemello L, Cavalleto L, Bernadinello E, Guido M, Pontisso P, Alberti A. The effect of interferon alpha and ribavirin combination therapy in naive patients with chronic hepatitis. J Hepatol 1995 ; 23 (suppl 2) : 8-12
82. 81 Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatits C genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatits C. Hepatology 1997 ; 25 : 1250-4
83. 82 Squadrito G, Leone F, Sartori M Nalpas B, Berthelot P, Raimondo G, Pol S, Bréchot C. HCV NS5A mutations and response of chronic hepatitis to alpha interferon. Hepatology 1996 ; 24 : 155A (Abstract)
84. 83 Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the non structural 5A protein. Virology 1997 ; 230 : 217-27
85. 84 Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay and an inhouse limiting dilution method. J Clin Microbiol 1997 ; 35 : 187-92
86. 85 Lunel F. HCV and autoimmunity: fortuitous association or reality ? Gastroenterology 1994 ; 107 : 1550-5 (Editorial)
87. 86 Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathology 1997 ; 19 (1): 111
88. 87 Choo Q, Kuo G, Ralston R, Weiner AJ, Chien D, Van Nest G, Han J et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994 ; 91 : 1294-8